E2F7 and central nervous system cancer: This study aims to identify the mechanism of temozolomide (TMZ) resistance in GBM.<h4>Methods</h4>Bioinformatics and antibody-based protein detection were used to examine the expression of E2F7 in gliomas and its correlation with prognosis.